Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
Slika profila

Ivan Krečak

37583

Ivan

Krečak

dr. sc.

nije evidentirano
Naziv Akcije
Krečak, Ivan ; Čeko, Monika ; Nižetić, Karla ; Čubrić, Eva ; Županović, Mediana ; Skelin, Marko ; Lucijanić, Marko Hematocrit to hemoglobin ratio (HHR) may improve prognostication in patients with pulmonary embolism // Scandinavian journal of clinical & laboratory investigation, 83 (2023), 3; 200-203. doi: 10.1080/00365513.2023.2191334
Lucijanic, Marko ; Krecak, Ivan ; Soric, Ena ; Sabljic, Anica ; Galusic, Davor ; Holik, Hrvoje ; Perisa, Vlatka ; Peric, Martina Moric ; Zekanovic, Ivan ; Kusec, Rajko Higher estimated plasma volume status is associated with increased thrombotic risk and impaired survival in patients with primary myelofibrosis // Biochemia medica, 33 (2023), 2; 020901, 8. doi: 10.11613/bm.2023.020901
Lucijanic, Marko ; Veic, Petra ; Aric, Ivona ; Tupek, Katarina Marija ; Soric, Ena ; Sabljic, Anica ; Vlasac Glasnovic, Josipa ; Stoos-Veic, Tajana ; Krecak, Ivan ; Kusec, Rajko Higher JAK2 V617F mutant allele burden in patients with chronic myeloproliferative neoplasms is associated with a higher prevalence of chronic kidney disease and unfavorable dynamics of kidney function over time // Annals of hematology, (2023), doi: 10.1007/s00277-023-05305-3
Lucijanić, Marko; Krečak, Ivan; Bušić, Iva; Atić, Armin; Stojić, Josip; Sabljić, Anica; Sorić, Ena; Veić, Petra; Marević, Sanja; Derek, Lovorka et al. Estimated plasma volume status in COVID-19 patients and its relation to comorbidities and clinical outcomes // Journal of thrombosis and thrombolysis, (2023),
Krečak, Ivan ; Grohovac, Dragana ; Vučenović Bašić, Nikolina ; Čeko, Monika ; Nižetić, Karla ; Sabljić, Anica ; Holik, Hrvoje ; Galušić, Davor ; Zekanović, Ivan ; Morić Perić, Martina et al. Clinical presentation, treatment patterns, and outcomes of pulmonary embolism in patients with chronic myeloproliferative neoplasms // Thrombosis research, (2023), doi: 10.1016/j.thromres.2023.03.004
Krečak, Ivan ; Zekanović, Ivan ; Morić Perić, Martina ; Holik, Hrvoje ; Coha, Božena ; Periša, Vlatka ; Lucijanić, Marko High plateletcrit may be associated with thrombotic risk in polycythemia vera // International journal of laboratory hematology, (2023), doi: 10.1111/ijlh.14073
Lucijanic, Marko ; Krecak, Ivan Pulmonary embolism, is it healthy to be volume expanded? // European journal of internal medicine, (2023), doi: 10.1016/j.ejim.2023.05.010
Holik, Hrvoje ; Lucijanic, Marko ; Krecak, Ivan Specific symptom burden in patients with chronic myeloproliferative neoplasms and chronic kidney disease // Annals of hematology, (2023), doi: 10.1007/s00277-023-05296-1
Lucijanić, Marko ; Krečak, Ivan ; Sorić, Ena ; Galušić, Davor ; Holik, Hrvoje ; Periša, Vlatka ; Morić Perić, Martina ; Zekanović, Ivan ; Kušec, Rajko Palpable spleen size is differently prognostic in primary and secondary myelofibrosis // Leukemia & lymphoma, 64 (2023), 4; 893-896. doi: 10.1080/10428194.2023.2179360
Krečak, Ivan ; Pivac, Ljerka ; Lucijanić, Marko ; Skelin, Marko Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms // Biomedicines, 11 (2023), 5; 1301, 16. doi: 10.3390/biomedicines11051301
nije evidentirano
nije evidentirano